Vai alla homepage
Spain
Tutte le città
820К+ pazienti hanno ricevuto assistenza dal 2014
50 paesi
1,500 cliniche
6K+ recensioni
3K+ Oltre 3.000 medici qualificati

Qual è il prezzo di Immunotherapy with Keytruda (Pembolizumab) in Spain? Scoprilo ora

The cost of immunotherapy with Keytruda (pembrolizumab) in Spain generally runs from $15,000 to $25,000. Pricing depends on factors such as the number of treatment cycles, the patient’s diagnosis, and the hospital’s location. In the United States, the average cost is $21,500 (per NCCN guidelines). This means immunotherapy with Keytruda in Spain is typically about 30% less than in the U.S.

Spanish hospitals usually include the drug itself, oncologist consultations, infusion sessions, and routine monitoring in the price. In the U.S., medication, administration, and follow-up visits are often billed separately. Always confirm what’s included with each clinic or hospital before starting treatment.

Vantaggi chiave

Why choose Spain for immunotherapy with Keytruda (Pembrolizumab)?

  • Accredited clinics: JCI-certified hospitals in Spain ensure high standards of care and patient safety.
  • Latest technologies: The use of modern devices, such as the latest infusion pumps and monitoring systems, ensures precise administration of Keytruda (Pembrolizumab).
  • High success rates: Keytruda has demonstrated an efficacy rate of 45% in treating certain types of cancers. This significantly improves patient outcomes.
  • Expert surgeons: Leading oncologists in Spain, many of whom are board-certified and have extensive experience, have successfully treated numerous cases with Keytruda. Their expertise contributes to its growing reputation.

Access advanced Immunotherapy with Keytruda (Pembolizumab) solutions in trusted clinics da $14,576.

Dati verificati da Bookimed a February 2026, basati sulle richieste dei pazienti e sulle offerte ufficiali di 59 cliniche in tutto il mondo. I costi mediani si basano su fatture reali (2024–2026) e sono aggiornati mensilmente. I prezzi effettivi possono variare.
Scritto da Anna Leonova
Responsabile del Team Content Marketing

I tuoi benefici e le tue garanzie con Bookimed

Prezzi diretti

Bookimed non aggiunge costi extra ai prezzi di Immunotherapy with Keytruda (Pembolizumab). Le tariffe provengono dai listini ufficiali delle cliniche. Pagherai direttamente in clinica per la tua Immunotherapy with Keytruda (Pembolizumab) al tuo arrivo.

Solo cliniche e medici verificati

Bookimed si impegna per la tua sicurezza. Lavoriamo solo con strutture che mantengono elevati standard internazionali in Immunotherapy with Keytruda (Pembolizumab) e hanno le licenze necessarie per servire pazienti internazionali in tutto il mondo.

Assistenza gratuita 24/7

Bookimed offre assistenza esperta gratuita. Un coordinatore medico personale ti supporta prima, durante e dopo il trattamento, risolvendo qualsiasi problema. Non sarai mai solo nel tuo percorso di Immunotherapy with Keytruda (Pembolizumab).

Perché noi?

Il tuo coordinatore medico Bookimed personale

  • Ti supporta in ogni fase
  • Aiuta a scegliere la clinica e il medico giusti
  • Garantisce un accesso rapido e semplice alle informazioni

Non perdere queste offerte esclusive di Immunotherapy with Keytruda (Pembolizumab) in Spain per febbraio 2026

Tipo di procedura
Guidelines of Memorial Sloan Kettering Cancer Center (USA). Keytruda (1 injection, 200 mg)

Spain, Barcelona

Joan Carles Galceran

39 anni di esperienza • 1200+ trattamenti eseguiti

Treatment follows the precise immunotherapy protocols of Memorial Sloan Kettering Cancer Center. Dr. Joan Carles Galceran, who has performed 1,200+ treatments, oversees the therapy after a personalized review by a multidisciplinary tumor board at the JCI-accredited Centro Médico Teknon. The package, costing around $14,460, includes a 200 mg Keytruda injection, an oncology consultation, and blood analysis with cancer markers. Part of the Quirónsalud group, the clinic provides international coordination and translator services.

Scopri le migliori cliniche di Immunotherapy with Keytruda (Pembolizumab) in Spain: 4 opzioni verificate e Prezzi

Le classifiche delle cliniche di Bookimed si basano su algoritmi di data science, offrendo un confronto affidabile, trasparente e oggettivo. Considerano la richiesta dei pazienti, i punteggi delle recensioni (positive e negative), la frequenza di aggiornamento di trattamenti e prezzi, la rapidità di risposta e le certificazioni delle cliniche.
Hospital Quiron Barcelona
Hospital HM Nou Delfos
GenesisCare Clinics

Panoramica di Immunotherapy with Keytruda (Pembolizumab) in Spain

Conclusioni
Procedure correlate e Costi
Come funziona
Cosa aspettarsi
Pro e Contro
Vantaggi
Pagamento
pazienti raccomandano -
85%
Richieste in corso - 46119
Recensioni verificate dei pazienti - 22
Commissioni Bookimed - $0

Ottieni una valutazione medica per Immunotherapy with Keytruda (Pembolizumab) in Spain: scegli il tuo specialista tra i migliori nel settore

Vedi tutti i medici
verificato

Francesc Bosch

126 anni di esperienza

Professor Bosch leads global research in Chronic Lymphocytic Leukemia (CLL) and lymphoma treatments, with over 80 active clinical trials.

  • Specializes in lymphomas and CLL at Hospital Quiron Barcelona
  • Published 100+ articles in top journals like NEJM and Nature Medicine
  • Head of Hematology at Vall d'Hebron University Hospital
  • Develops new therapeutic approaches for lymphoproliferative disorders
verificato

Lopez Ibor

32 anni di esperienza

Dr. López-Ibor leads the Pediatric Hematology and Oncology Unit at HM Montepríncipe Hospital, specializing in bone, brain tumors, and leukemia.

  • Over 20 years of pediatric oncology experience
  • Expert in Hematology and Oncology from the University of Maryland
  • Author of numerous national and international scientific publications
  • Provides specialized care for children and adolescents
verificato

Jesus Soberino

18 anni di esperienza

Dr. Jesus Soberino is an oncologist at Vall d’Hebron University Hospital and the Vall d’Hebron Institute of Oncology (VHIO). He specializes in breast cancer and melanoma. Dr. Soberino has led many phase 1–3 clinical trials. His work has helped approve important drugs, including CDK4/6 inhibitors for metastatic breast cancer and immunotherapies for melanoma.

His areas of expertise include endocrine therapy, managing hormone resistance, and developing new immunotherapies. Dr. Soberino is known for his patient-centered care. He actively collaborates in research to improve cancer treatment. He is accredited by VHIO and is a key member of the Breast Cancer and Melanoma Units.

verificato

Joan Albanell Mestres

37 anni di esperienza

Dr. Joan Albanell Mestres is a leading oncologist who specializes in breast cancer. He earned his MBBS from the University Autónoma de Barcelona in 1989. He leads the breast cancer program at HM Delfos and oversees Oncology services at Clin del Mar in Spain.

Dr. Albanell has published 120 scientific articles, with over 9,000 citations. He directs cancer research at Del Mar. He is also an active member of GEICAM, CIBERONC, AIECA, and SEOM. He regularly contributes to important oncology research.

Storie in video dei pazienti Bookimed

Amanda
My companion and I were treated with such kindness — I have nothing but admiration for the entire team.
Procedura: Mastectomy
Randolph
Stay strong, stay informed, and never underestimate the power of cutting-edge treatments and a solid support system.
Procedura: Radioembolization for liver cancer
Niculcea
It’s a tough path — but we’re not walking it alone. And that means everything. Thanks to Bookimed again.
Procedura: Lutetium-177 therapy
Jakob Jogisuu
13 mar 2019
Recensione verificata.
Mansour
8 nov 2023
Recensione verificata.
As a doctor I recommend bookimed
Natalia Rayskiy
30 dic 2019
Recensione verificata.
Мы очень довольны клиникой Sant Joan de Deu, в которой наблюдается наш ребёнок
Надежда Sergiyenko
11 giu 2019
Recensione verificata.
Recensione anonima
27 mar 2025
Recensione verificata.
Overall, I had a positive experience and would recommend it to others
Karen
17 mag 2022
Recensione verificata.
I saw Dr
Charlene
23 mag 2022
Recensione verificata.
Алена
18 dic 2023
Recensione verificata.
The coordinator Yulia is an excellent specialist
Ірина
7 apr 2023
Recensione verificata.
Recensione anonima
1 feb 2020
Recensione verificata.
-Let me express my deepest gratitude for your care, admiration of your greatest talent and your positive, super-nice personality!
Наталья
25 set 2019
Recensione verificata.
- Thank!
Recensione anonima
19 ago 2019
Recensione verificata.
"Thanks a lot to Bookimed, and especially to my coordinating doctor Ekaterina Koliko
Елена Коросташевская
11 giu 2018
Recensione verificata.
- I am sincerely grateful for Doctor-coordinator Christina's help Return: About the doctor: - I am sincerely grateful for Doctor-coordinator Christina's help - I want to thank all the doctors who directly have treated me, especially Dr
Natalia Rayskiy
11 set 2019
Recensione verificata.
Инна
11 feb 2020
Recensione verificata.
Dr

Condividi contenuto

Aggiornato: 03/27/2025
Scritto da
Anna Leonova
Anna Leonova
Responsabile del Team Content Marketing
Copywriter medico certificato con oltre 10 anni di esperienza, ha sviluppato i contenuti affidabili di Bookimed, con il supporto di un Master in filologia e interviste con esperti medici da tutto il mondo.
Revisione da parte di Consulente medico Bookimed
Fahad Mawlood
Editor medico e Data Scientist
Medico generico. Vincitore di 4 premi scientifici. Ha lavorato in Asia Occidentale. Ex capo del team medico per i pazienti di lingua araba. Ora responsabile dell'elaborazione dei dati e dell'accuratezza dei contenuti medici.
Fahad Mawlood Linkedin
Questa pagina può includere informazioni relative a varie condizioni mediche, trattamenti e servizi sanitari disponibili in diversi paesi. Si prega di notare che il contenuto è fornito solo a scopo informativo e non deve essere interpretato come consiglio o indicazione medica. Si prega di consultare il proprio medico o un professionista sanitario qualificato prima di iniziare o modificare un trattamento medico.

Dati chiave su Immunotherapy with Keytruda (Pembolizumab)

Immunotherapy with Keytruda (Pembolizumab)

Keytruda, a form of immune-based therapy, leverages the body's immune system to target and destroy cancer cells using monoclonal antibodies.

Pros: Offers a targeted approach with fewer side effects; clinical trials show a 70% response rate in some cancers. Suitable for varied cancer types due to its immune modulation properties.
Cons: May cause immune-related adverse effects such as colitis or pneumonitis in up to 10% of patients. Limited effectiveness in tumors with low PD-L1 expression.
Effectiveness: 70% response rate in some cancer types.
Duration: Each session lasts about 30 minutes.
Recovery: Not needed.
Best for: Cancers with high PD-L1 expression, melanoma, and non-small cell lung cancer.
Prices: Costo di Immunotherapy with Keytruda (Pembolizumab) in Spain da $15,000

Richiedi una consulenza gratuita

Seleziona il modo migliore per essere contattato